The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

We all know headphones can be bad for your hearing if you listen to sounds too loudly in close proximity to your ears. But a BBC report suggests that a new health scare could be emerging around ...

NEW YORK – Galapagos said Monday that it has partnered with NecstGen, a contract development and manufacturing organization (CDMO), to support decentralized manufacturing of Galapagos' cell therapy ...

NEW YORK – Cancer diagnostics firm Imagene on Wednesday announced that it is collaborating with Tempus AI to launch an AI-based biomarker prediction panel for non-small cell lung cancer. Imagene's ...